Latest Growth Strategy News

Mach7 Technologies Limited reported a 16% revenue increase to AUD 33.8 million for FY25, alongside a 22% reduction in net loss, driven by a strategic shift to subscription-based sales and disciplined cost management.

Duratec Limited reported record FY25 results with revenue of $573 million and a robust $4.16 billion project pipeline, driven by strong Energy and Emerging sectors growth. Despite Defence sector delays, the company is well positioned for expansion in FY26.

Lovisa Holdings Limited reported a 14.2% revenue increase to A$798.1 million for FY25, driven by a net addition of 131 stores globally. Profit after tax rose 4.8% to A$86.3 million, while the company declared a final unfranked dividend of 27 cents per share.

Apiam Animal Health reported modest revenue growth but a sharp net profit decline in FY25, launching a Strategic Reset program under new leadership. The company also received a $0.88 per share acquisition proposal from Adamantem Capital Management.

EDU Holdings Limited has reported a remarkable half-year performance for 2025, with revenue more than doubling and profitability surging, prompting the company to declare its first-ever interim dividend.

ParagonCare Limited reported a solid FY25 with $3.6 billion in revenue and $95.2 million underlying EBITDA, marking progress in its integration and growth strategy across Asia Pacific. The company is poised for further profitability improvements and expansion in FY26.

Australian Finance Group Ltd (AFG) reported a 21% rise in statutory net profit after tax to $35 million for FY25, driven by record broker numbers and loan book growth. The company declared a fully franked final dividend of 5.3 cents per share, underscoring strong shareholder returns.

Horizon Minerals is progressing its Pre-Feasibility Study to convert the Black Swan plant to gold production, aiming for a 1.5Mtpa throughput and a Financial Investment Decision by early 2026.

EBOS Group Limited reported solid FY25 results with 12% revenue growth and strategic acquisitions, setting sights on continued expansion and operational efficiency in FY26.

Marvel Gold Limited has restructured its Mali asset sale with Anchises Capital, securing a $250,000 equity injection while revising terms for its Tabakorole Gold Project sale.

WCM Global Growth Limited reported a robust FY2025 with a 31% portfolio return and raised its fully franked final dividend, alongside an upgraded progressive dividend policy and a shareholder-friendly DRP discount.

Microba Life Sciences reported a 30% increase in revenue to $15.7 million for FY25, driven by strong growth in its core microbiome diagnostic products and successful UK market expansion. Despite narrowing its net loss to $14.9 million, the company is focused on scaling diagnostics adoption and achieving break-even in FY26.